Literature DB >> 8556833

Effects of chromium and guar on sugar-induced hypertension in rats.

H G Preuss1, J A Gondal, E Bustos, N Bushehri, S Lieberman, N A Bryden, M M Polansky, R A Anderson.   

Abstract

Ingestion of sugars (sucrose, fructose, glucose) by various rat strains is associated with perturbations in the glucose/insulin system and higher systolic blood pressure (SBP). The association suggests causality, because alterations in insulin metabolism have been found in essential hypertension and many experimental forms of hypertension. To test the hypothesis that sugar-induced SBP elevation is secondary to perturbed insulin metabolism, we examined in 2 experiments effects of chromium and guar, substances known to affect insulin metabolism, on SBP of Spontaneously Hypertensive Rats (SHR). In both studies, sucrose compared to starch ingestion caused significant elevation of SBP; but addition of 2 chromium nicotinate complexes and guar prevented development of sugar-induced SBP elevations. The basal, genetic hypertension of the SHR was not affected by either nutrient. An additional finding in the first study was that sugar-consuming SHR supplemented with chromium had greater BW and increased organ weight (kidney, spleen, and liver) than nonsupplemented SHR. Accordingly, we have shown that two different mechanisms known to ameliorate insulin perturbations, use of chromium and guar, prevent sugar-induced SBP elevations. Since essential hypertension may be due to insulin perturbations and high dose chromium supplementation seems nontoxic, this may prove to be a useful means to lower blood pressure (BP) in some essential hypertensives, as well as diabetic hypertensives. Soluble fiber in the form of guar is also quite effective in favorably influencing sugar-induced SBP elevations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8556833

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  7 in total

1.  Enhanced insulin-hypoglycemic activity in rats consuming a specific glycoprotein extracted from maitake mushroom.

Authors:  Harry G Preuss; Bobby Echard; Debasis Bagchi; Nicholas V Perricone; Cun Zhuang
Journal:  Mol Cell Biochem       Date:  2007-08-01       Impact factor: 3.396

2.  Beneficial effects of a novel IH636 grape seed proanthocyanidin extract and a niacin-bound chromium in a hamster atherosclerosis model.

Authors:  J A Vinson; M A Mandarano; D L Shuta; M Bagchi; D Bagchi
Journal:  Mol Cell Biochem       Date:  2002-11       Impact factor: 3.396

3.  Effects of oral glucosamine and chondroitin sulfate alone and in combination on the metabolism of SHR and SD rats.

Authors:  B W Echard; N A Talpur; K A Funk; D Bagchi; H G Preuss
Journal:  Mol Cell Biochem       Date:  2001-09       Impact factor: 3.396

4.  Antihypertensive and metabolic effects of whole Maitake mushroom powder and its fractions in two rat strains.

Authors:  Nadeem A Talpur; Bobby W Echard; Arthur Yin Fan; Omeed Jaffari; Debasis Bagchi; Harry G Preuss
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

5.  Effects of niacin-bound chromium, Maitake mushroom fraction SX and (-)-hydroxycitric acid on the metabolic syndrome in aged diabetic Zucker fatty rats.

Authors:  Nadeem Talpur; Bobby W Echard; Taharat Yasmin; Debasis Bagchi; Harry G Preuss
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

6.  High dose astaxanthin lowers blood pressure and increases insulin sensitivity in rats: are these effects interdependent?

Authors:  Harry G Preuss; Bobby Echard; Eiji Yamashita; Nicholas V Perricone
Journal:  Int J Med Sci       Date:  2011-02-09       Impact factor: 3.738

7.  Inhibition by natural dietary substances of gastrointestinal absorption of starch and sucrose in rats 2. Subchronic studies.

Authors:  Harry G Preuss; Bobby Echard; Debasis Bagchi; Sidney Stohs
Journal:  Int J Med Sci       Date:  2007-08-10       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.